GeneDx Holdings Corp reports results for the quarter ended December 31 - Earnings Summary

GeneDx Holdings

18/02/2025 14:31

* GeneDx Holdings Corp  WGS.OQ  reported quarterly adjusted
earnings of 62 cents​​ per share for the quarter ended December
31, higher than the same quarter last year, when the company
reported EPS of -69 cents.  The mean expectation of six analysts
for the quarter was for earnings of 16 cents per share. Wall
Street expected results to range from 3 cents to 34 cents per
share.
    * Revenue rose 66.6% to $95.64 million from a year ago;
analysts
expected $82.23 million. 
    * GeneDx Holdings Corp's reported EPS for the quarter was 23
cents​.
    * The company reported quarterly net income of $5.44
million.
    * GeneDx Holdings Corp shares had fallen by 0.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 51.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for GeneDx Holdings
Corp is $85.00 
This summary was machine generated from LSEG data February 18 at
02:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.16           0.62           Beat
 Sep. 30 2024      -0.21          0.04           Beat
 Jun. 30 2024      -0.30          -0.10          Beat
 Mar. 31 2024      -0.67          -0.33          Beat